Identification of interleukin-16 production on tumor aggravation in hepatocellular carcinoma by a proteomics approach
Open Access
- 9 December 2021
- journal article
- Published by IOS Press in Tumor Biology
- Vol. 43 (1), 309-325
- https://doi.org/10.3233/tub-211507
Abstract
BACKGROUND: Cytokines play an important role in the immune response, angiogenesis, cell growth, and differentiation in hepatocellular carcinoma (HCC). OBJECTIVE: We performed a comprehensive study to identify tumor-related cytokines and pathways involved in HCC pathogenesis. METHODS: Cytokine production was evaluated in human HCC tissues and adjacent non-tumor tissues using an antibody-based protein array technique. We compared cytokine expression in HCC tissues with that of hepatic hemangioma (HH), liver metastasis of colorectal cancer, and noncancerous liver tissues from transplantation donors. The protein levels and localization of the candidate cytokines were analyzed by western blotting and immunohistochemistry. RESULTS: Increased expression of interleukin (IL)-1 receptor antagonist, macrophage migration inhibitory factor, and IL-16 was observed in HCC and paired adjacent non-tumor tissues compared with noncancerous livers. In addition, there were increased IL-16 levels in HCC tissues compared with HH. IL-16 treatment significantly increased cell proliferation in vitro. The expression of extracellular signal-regulated kinase (ERK)1/2 and cyclin D1 was markedly increased in cells from two HCC cell lines, Huh7 and HepG2, in a dose- and time-dependent manner. Phosphorylated to total ERK1/2 ratio was increased in Huh7 cells following IL-16 50 ng/ml, but not HepG2 cells. ERK phosphorylation have occurred earlier than protein accumulation at 48 h. Pretreatment with the ERK inhibitor, FR18024, or an anti-IL-16 antibody reduced the increase in IL-16 production in HCC cells. CONCLUSIONS: These results suggest that cell proliferation induced by IL-16 is mediated through the ERK pathway, thus, we identified a new factor associated with HCC tumor growth.Keywords
This publication has 33 references indexed in Scilit:
- IL-16 effects on A549 lung epithelial cells: Dependence on CD9 as an IL-16 receptor?Journal of Immunotoxicology, 2009
- Comparison of Cytokine Expression in Mesenchymal Stem Cells from Human Placenta, Cord Blood, and Bone MarrowJournal of Korean Medical Science, 2009
- Roles of the Raf/MEK/ERK pathway in cell growth, malignant transformation and drug resistanceBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 2007
- A cytokine-mediated link between innate immunity, inflammation, and cancerJCI Insight, 2007
- Hepatocellular carcinoma pathogenesis: from genes to environmentNature Reviews Cancer, 2006
- The role of cytokines in hepatocellular carcinomaJournal of Leukocyte Biology, 2006
- Evaluation of Extracellular Signal Regulated Kinase Expression and Its Relation to Treatment of Hepatocellular CarcinomaJournal of the American College of Surgeons, 2005
- Inflammation and cancerNature, 2002
- The associated regulators and signal pathway in rIL-16/CD4 mediated growth regulation in Jurkat cellsCell Research, 2002
- Interleukin 16 and its function as a CD4 ligandImmunology Today, 1996